Submit Manuscript

Asian Journal of Animal and Veterinary Advances

Year: 2011 | Volume: 6 | Issue: 11 | Page No.: 1034-1036
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
Commentary

Urtica dioica Improves Glucose Control in Diabetes on the Basis of Animal Studies

Parisa Sarkhail
Received: May 05, 2011;   Accepted: August 06, 2011;   Published: September 28, 2011
A comprehensive review on the Urtica dioica (common nettle) was recently published (Mehri et al., 2011) that revealed a lot of information about its efficacy and safety for management of type 2 diabetes and its complications. Urtica dioica has a long use tradition as an expectorant, antidiarrheal and for treatment of menstrual, hemorrhage, diabetes, rheumatism, eczema and anemia. Although at present, nettle root has a prominent position for treatment of Benign Prostatic Hyperplasia (BPH) (Akbay et al., 2003), several beneficial medical properties are currently attributed to this plant, such as antidiabetic, anti rheumatoid arthritis or osteoarthritis and diuretic (Chrubasik et al., 2007).

On the basis of Mehri et al. (2011) review, the most animal studies are in favor of benefits of U. dioica in diabetes, but only one human study showed efficacy of this herb when used in combination in the form of Glucolevel tablets. Moreover, one case study has been reported about hypoglycemia after taking herbal remedy for benign prostatic hypertrophy (Edgcumbe and McAuley, 2008). Nevertheless, latest researches on the pharmacological effects of isolated compounds from U. dioica support these findings (Chrubasik et al., 2007). In the recent year, dietary polyphenolic phytochemicals have received considerable recent attention as alternative candidates for treatment of diabetes (Rahimi et al., 2005; Momtaz and Abdollahi, 2010) and evidences confirm that U. dioica is a rich source of polyphenolic compounds (Chrubasik et al., 2007). One of the main bioactive isolated phenolic Compounds, Chlorogenic Acid (CGA), from this plant has been found as a potent hypoglycemic (Karthikesan et al., 2010) agent and antioxidant (Kahkonen et al., 2001). CGA can decrease the blood glucose levels and inhibit glucose-6-phosphatase (G-6-Pase), the key enzyme that catalyzes the final step of glycogenesis (release of glucose from the liver) (Hoseini et al., 2006) and gluconegensis (promotes the uptake of glucose by liver cells) and regulate overproduction of both glucose by inhibiting G-6-pase; thereby it controls glycemic status in type 2 diabetes (Karthikesan et al., 2010). Moreover, some flavonol glycosides have been found in this plant such as rutin that may potentially play a positive role in carbohydrate metabolism and protection of the functional β-cells to increase secretion of insulin from islets in diabetes (Prince and Kamalakkannan, 2006). Furthermore, compounds that structurally related cyclical peptides have shown to facilitate glucose uptake by forming unique glucose permeable pores (Domola et al., 2010).

Consideration all these findings, as well as data in the review by Mehri et al. (2011), it is apparent that U. dioica can decrease blood glucose by several mechanisms including pancreatic and extra pancreatic mechanisms especially antioxidant potentials (Hasani-Ranjbar et al., 2009). Despite its protective functions, few accessible research data showed that U. dioica causes some side effects in the kidney and liver (Mehri et al., 2011). Probably some compounds in U. dioica can cause kidney and other internal organs damage. For instance, one investigation on Chinese herbal medicine indicated that CGA induces liver and kidney injury in dogs (Li et al., 2010). However, Setarud (IMOD)TM that is a combination of Urtica and two other extracts has shown antidiabetic activity (Mohseni-Salehi-Monfared et al., 2010) without any serious side effects (Khairandish et al., 2009) or genotoxic adverse effects (Khorram Khorshid et al., 2008).

Although, there is no evidence that U. dioica directly produces renal or hepatic toxicity in human, but it should be standardized on the basis of active compounds and for more information on toxic doses and mechanisms. Therefore, high-profile animal and clinical studies should be planned. As combined herbal formulation containing nettle has been shown to be effective and safe for control of hyperglycemia (Said et al., 2008), type 2 diabetic patients can receive them as a supplement and regularly renal and hepatic function can be monitored in these patients.

REFERENCES

  1. Akbay, P., A.A. Basaran, U. Undeger and N. Basaran, 2003. In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L. Phytother. Res., 17: 34-37.
    CrossRefPubMedDirect Link
  2. Chrubasik, J.E., B.D. Roufogalis, H. Wagner and S.A. Chrubasik, 2007. A comprehensive review on nettle effect and efficacy profiles, Part I: Herba urticae. Phytomedicine, 14: 423-435.
    PubMed
  3. Domola, M.S., V. Vu, C.A. Robson-Doucette, G. Sweeney and M.B. Wheeler, 2010. Insulin mimetics in Urtica dioica: Structural and computational analyses of Urtica dioica extracts. Phytother. Res., 24: S175-S182.
    CrossRef
  4. Edgcumbe, D.P and D. McAuley, 2008. Hypoglycaemia related to ingestion of a herbal remedy. Eur. J. Emerg. Med., 15: 236-237.
  5. Hasani-Ranjbar, S., B. Larijani and M. Abdollahi, 2009. A systematic review of the potential herbal sources of future drugs effective in oxidant-related diseases. Inflamm. Allergy Drug Targets, 8: 2-10.
    CrossRefPubMedDirect Link
  6. Hoseini, S., H. Esmaily, A. Mohammadirad and M. Abdollahi, 2006. Effects of sildenafil a phosphodiesterase 5 inhibitor on rat liver cell key enzymes of gluconeogenesis and glycogenolysis. Int. J. Pharmacol., 2: 280-285.
    CrossRefDirect Link
  7. Kahkonen, M.P., A.I. Hopia and M. Heinonen, 2001. Berry phenolics and their antioxidant activity. J. Agric. Food Chem., 49: 4076-4082.
    CrossRefDirect Link
  8. Karthikesan, K., L. Pari and V.P. Menon, 2010. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen. Physiol. Biophys., 29: 23-30.
    PubMedDirect Link
  9. Khairandish, P., M. Mohraz, B. Farzamfar, M. Abdollahi and M.H. Shahhosseiny et al., 2009. Preclinical and phase 1 clinical safety of Setarud (IMODTM), a novel immunomodulator. DARU, 17: 148-156.
    Direct Link
  10. Khorram-Khorshid, H.R.K., Y.A. Novitsky, M. Abdollahi, M.H. Shahhosseiny and B. Sadeghi et al., 2008. Studies on potential mutagenic and genotoxic activity of Setarud. Daru, 16: 223-228.
    Direct Link
  11. Li, B.Q., X. Dong, G.Q. Yang, S.H. Fang and J.Y. Gao et al., 2010. Role of chlorogenic acid in the toxicity induced by Chinese herbal injections. Drug Chem. Toxicol., 33: 415-420.
    PubMed
  12. Mehri, A., S. Hasani-Ranjbar, B. Larijani and M. Abdollahi, 2011. A systematic review of efficacy and safety of Urtica dioica in the treatment of diabetes. Int. J. Pharmacol., 7: 161-170.
    CrossRefDirect Link
  13. Mohseni-Salehi-Monfared, S.S., E. Habibollahzadeh, H. Sadeghi, M. Baeeri and M. Abdollahi, 2010. Efficacy of Setarud (IMODTM), a novel electromagnetically-treated multi-herbal compound, in mouse immunogenic type-1 diabetes. Arch. Med. Sci., 6: 663-669.
    CrossRef
  14. Momtaz, S. and M. Abdollahi, 2010. An update on pharmacology of Satureja species; From antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. Int. J. Pharmacol., 6: 346-353.
    CrossRefDirect Link
  15. Rahimi, R., S. Nikfar, B. Larijani and M. Abdollahi, 2005. A review on the role of antioxidants in the management of diabetes and its complications. Biomed. Pharmacother., 59: 365-373.
    PubMedDirect Link
  16. Said, O., S. Fulder, K. Khali, H. Azaizeh, E. Kassis and B. Saad, 2008. Maintaining a physiological blood glucose level with 'glucolevel', a combination of four anti-diabetes plants used in traditional Arab herbal medicine. Evidence-Based Complementary Alternative Med., 5: 421-428.
    CrossRefDirect Link
  17. Prince, P.S.M. and N. Kamalakkannan, 2006. Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol., 20: 96-102.
    CrossRefPubMedDirect Link

Leave a Comment

Your email address will not be published. Required fields are marked *